Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2150.0000 (7.5%) ($2000.0000 - $2150.0000) on Tue. Sep. 25, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.93% (three month average) | RSI | 0 | Latest Price | $2150.0000(7.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 7.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 44.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWJ(0%) FXI(-0%) IWM(0%) OIH(0%) PEJ(-0%) | Factors Impacting CAPR price | CAPR will decline at least -7.965% in a week (0% probabilities). GLD(-4%) TLT(-3%) TIP(-3%) XLU(-2%) EWP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.965% (StdDev 15.93%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
5 Day Moving Average | $1930(11.4%) | 10 Day Moving Average | $1552.2(38.51%) | 20 Day Moving Average | $1295.65(65.94%) | To recent high | 0% | To recent low | 273.9% | Market Cap | $42.35b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |